Carnitine-acylcarnitine translocase deficiency in three neonates presenting with rapid deterioration and cardiac arrest

Hong Kong Medical Journal

Volumn 13, Issue 1, 2007, Pages 66-68

  Lee, Robert S Y ^a   Lam, C W ^b   Lai, C K ^a   Yuen, Y P ^a   Chan, K Y ^a   Shek, C C ^a   Chan, Albert Y W ^a   Chow, C B ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Carnitine acyltransferases; Deficiency; Sudden infant death

Indexed keywords

ACYLCARNITINE; ACYLCARNITINE CARNITINE TRANSLOCASE; CARRIER PROTEIN; FATTY ACID; GLUCOSE; UNCLASSIFIED DRUG;

ARTICLE; CARDIOPULMONARY INSUFFICIENCY; CARNITINE ACYLCARNITINE TRANSLOCASE DEFICIENCY; CASE REPORT; CHILD DEATH; DETERIORATION; DISEASE ASSOCIATION; ENZYME DEFICIENCY; FATTY ACID OXIDATION; FEMALE; HEART ARREST; HUMAN; HYPERAMMONEMIA; HYPOGLYCEMIA; MALE; NEWBORN; RESUSCITATION; SURVIVAL; TREATMENT RESPONSE;

CARDIOPULMONARY RESUSCITATION; CARNITINE ACYLTRANSFERASES; FATAL OUTCOME; FEMALE; HEART ARREST; HUMANS; INFANT, NEWBORN; MALE; MEMBRANE TRANSPORT PROTEINS; MUTATION; RESPIRATORY INSUFFICIENCY;

EID: 33947588610     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rubio-Gozalbo ME, Vos P, Forget PP, et al. Carnitine-acylcarnitine translocase deficiency: case report and review of the literature. Acta Paediatr 2003;92:501-4.
2. Iacobazzi V, Invernizzi F, Baratta S, et al. Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency. Hum Mutat 2004;24:312-20.
3. Galron D, Birk OS, Kazanovitz A, Moses SW, Hershkovitz E. Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient. J Inherit Metab Dis 2004;27:267-73.
4. Lam CW, Lai CK, Chow CB, et al. Ethnic-specific splicing mutation of the carnitine-acylcarnitine translocase gene in a Chinese neonate presenting with sudden unexpected death. Chin Med J (Engl) 2003;116:1110-2.
5. Rubio-Gozalbo ME, Bakker JA, Waterham HR, Wanders RJ. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects. Mol Aspects Med 2004;25:521-32.
6. Olpin SE, Bonham JR, Downing M, et al. Carnitine-acylcarnitine translocase deficiency - a mild phenotype. J Inherit Metab Dis 1997;20:714-5.
7. Chalmers RA, Stanley CA, English N, Wigglesworth JS. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death. J Pediatr 1997;131:220-5.
8. al Aqeel AI, Rashed MS, Wanders RJ. Carnitine-acylcarnitine translocase deficiency is a treatable disease. J Inherit Metab Dis 1999;22:271-5.
9. Hoffmann GI, Nyhan WL, Zschacke J, Kahler SG, Mayatepek E, editors. Inherited metabolic diseases. 1st ed. Philadelphia: Lippincott Williams and Wilkins; 2002:82.
10. Saudubray JM, Martin D, de Lonlay P, et al. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 1999;22:488-502.
11. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 1989;83:927-36.